OR WAIT null SECS
August 30, 2022
Scientists have developed a mouse model that could be a promising model system for research into factors affecting mammalian embryonic development and disease.
Novavax’s COVID-19 vaccine, Nuvaxovid, can now be given to adolescents aged 12 to 17 in the UK.
Canvax’s new inorganic pyrophosphate is designed for in-vitro transcription reactions.
August 29, 2022
The European Union publishes long-awaited changes to Annex 1.
Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.
August 26, 2022
Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.
ChargePoint Technology has acquired single-use container company PuroVaso.
August 24, 2022
Anthony Fauci announced that he plans to step down as Director of the National Institute of Allergy and Infectious Diseases in December 2022.
Aerie to be purchased by Alcon after recently bringing two glaucoma drugs to market.
August 23, 2022
NICE has recommended the use of Tavneos (avacopan) in combination with rituximab or cyclophosphamide regimen.